We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
- Authors
Gershlick, A H; Spriggins, D; Davies, S W; Syndercombe Court, Y D; Timmins, J; Timmis, A D; Rothman, M T; Layton, C; Balcon, R
- Abstract
To study the effect of epoprostenol (prostacyclin, PGI2) given before, during, and for 36 h after coronary angioplasty on restenosis at six months and to evaluate the transcardiac gradient of platelet aggregation before and after percutaneous transluminal coronary angioplasty (PTCA) in treated and placebo groups.
- Publication
British heart journal, 1994, Vol 71, Issue 1, p7
- ISSN
0007-0769
- Publication type
Journal Article
- DOI
10.1136/hrt.71.1.7